The performance of companies tied to Viagra's past presents a intricate investment scenario . While the initial boom generated substantial returns , generic competition have significantly impacted revenue. Investing in related pharmaceutical businesses now requires a thorough assessment of intellectual property safeguards, evolving medical changes,